Mitoxantrone Clinical Trials

• Phase I Study of Weekly Intravenous PS-341 Plus Mitoxantrone
  ClinicalTrials.gov Identifier: NCT00059631 - Active, not recruiting
  Prostate Cancer
  
• Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002498 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002544 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00082680 - Active, not recruiting
  recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003183 - Active, not recruiting
  stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003003 - Active, not recruiting
  recurrent adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL
  ClinicalTrials.gov Identifier: NCT00185445 - Active, not recruiting
  Non Hodgkin Lymphoma
  
• Hormone Therapy With or Without Mitoxantrone and Prednisone in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004124 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; ...
  
• Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence
  ClinicalTrials.gov Identifier: NCT00003858 - Active, not recruiting
  stage III prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate; stage IV prostate cancer; stage I prostate cancer
  
• Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
  ClinicalTrials.gov Identifier: NCT00577993 - Active, not recruiting
  Lymphoma
  
• Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
  ClinicalTrials.gov Identifier: NCT00015951 - Active, not recruiting
  recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002576 - Active, not recruiting
  Lymphoma
  
• Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00182741 - Active, not recruiting
  Prostate Cancer
  
• Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF and Rituximab
  ClinicalTrials.gov Identifier: NCT00208975 - Recruiting
  Lymphoma
  
• Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00447473 - Recruiting
  Prostatic Neoplasms
  
• Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002688 - Active, not recruiting
  Leukemia, Myeloid
  
• Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00004197 - Active, not recruiting
  Lymphoma
  
• Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00268242 - Recruiting
  Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia
  
• Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00274963 - Recruiting
  Leukemia
  
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00470197 - Recruiting
  Leukemia
  
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00407966 - Recruiting
  Leukemia
  
• Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer
  ClinicalTrials.gov Identifier: NCT00546377 - Recruiting
  Leukemia; Lymphoma
  
• Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003343 - Active, not recruiting
  stage IV prostate cancer
  
• Gemtuzumab Ozogamicin in Combination with A-HAM in Refractory AML (GO-A-HAM)
  ClinicalTrials.gov Identifier: NCT00143975 - Active, not recruiting
  Leukemia, Myeloid, Acute
  
• Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002905 - Active, not recruiting
  AIDS-related peripheral/systemic lymphoma
  
• Ixabepilone, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00331344 - Recruiting
  Prostate Cancer
  
• XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (TROPIC)
  ClinicalTrials.gov Identifier: NCT00417079 - Recruiting
  Neoplasms; Prostatic Neoplasms
  
• Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC
  ClinicalTrials.gov Identifier: NCT00180167 - Recruiting
  Leukemia, Nonlymphocytic, Acute
  
• Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00119730 - Active, not recruiting
  Mantle Cell Lymphoma
  
• Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias
  ClinicalTrials.gov Identifier: NCT00410423 - Recruiting
  Relapsed Acute Leukemia; Refractory Acute Leukemia
  
• Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00477087 - Recruiting
  Prostate Cancer
  
• High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003032 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy Plus Filgrastim in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00032149 - Active, not recruiting
  AIDS-Related Lymphoma
  
• Vinblastine, Cyclophosphamide, Procarbazine, Prednisolone, Etoposide, Mitoxantrone, and Bleomycin in Treating Older Patients With Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00079105 - Recruiting
  stage I adult Hodgkin's lymphoma; stage II adult Hodgkin's lymphoma; stage III adult Hodgkin's lymphoma; stage IV adult Hodgkin's lymphoma
  
• Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00010075 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003893 - Active, not recruiting
  stage I breast cancer
  
• Combination Chemotherapy in Treating Pain in Patients With Hormone Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003232 - Active, not recruiting
  Pain; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life
  
• Study of Rebif® Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After Mitoxantrone
  ClinicalTrials.gov Identifier: NCT00283140 - Recruiting
  Relapsing Remitting Multiple Sclerosis
  
• Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00006114 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy in Treating Patients With Lymphoma
  ClinicalTrials.gov Identifier: NCT00002835 - Active, not recruiting
  Lymphoma
  
• Phase II Study of Irofulven in Patients with Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00124566 - Active, not recruiting
  Prostate Cancer
  
• Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00183989 - Recruiting
  Mantle Cell Lymphoma
  
• Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients with Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00024492 - Completed
  Tumors
  
• Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003633 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Comparison of Three Combination Chemotherapy Regimens in Treating Women With Stage I or Stage II Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004237 - Active, not recruiting
  stage I breast cancer; stage II breast cancer
  
• A Phase I/II Study of AMD3100 With Mitoxantrone, Etoposide and Cytarabine (AMD3100+MEC) in Relapsed or Refractory AML
  ClinicalTrials.gov Identifier: NCT00512252 - Recruiting
  Relapsed or Refractory AML
  
• Combination Therapy in Treating Patients With Advanced Prostate Cancer That Have Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00004001 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)
  ClinicalTrials.gov Identifier: NCT00452387 - Recruiting
  Metastatic Prostate Cancer
  
• Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002531 - Active, not recruiting
  non-T, non-B adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; B-cell adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002517 - Active, not recruiting
  Myeloid Leukemia; Myelodysplastic Syndromes; Refractory Anemia
  
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005847 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002674 - Active, not recruiting
  accelerated phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ...
  
• Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00017563 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003068 - Active, not recruiting
  stage IIIB breast cancer; Drug Toxicity; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer
  
• Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003650 - Active, not recruiting
  stage I childhood lymphoblastic lymphoma; stage II childhood lymphoblastic lymphoma; stage III childhood lymphoblastic lymphoma; ...
  
• Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005985 - Active, not recruiting
  Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; Non-Hodgkin's Lymphoma
  
• Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00005823 - Active, not recruiting
  Acute Myeloid Leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; ...
  
• Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002658 - Active, not recruiting
  Myeloid Leukemia; Neutropenia
  
• Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002766 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; adult acute lymphoblastic leukemia; adult lymphoblastic lymphoma; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003297 - Active, not recruiting
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005998 - Active, not recruiting
  Hodgkin's Disease; Lymphocytic Lymphoma
  
• Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00052299 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002701 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute promyelocytic leukemia (M3)
  
• Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients with HIV Associated Large Cell and Immunoblastic Lymphomas
  ClinicalTrials.gov Identifier: NCT00002003 - Completed
  Lymphoma, Non-Hodgkin; HIV Infections
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003957 - Active, not recruiting
  recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; ...
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005802 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia
  
• Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003602 - Active, not recruiting
  untreated adult acute myeloid leukemia; refractory anemia with excess blasts; refractory anemia with excess blasts in transformation; ...
  
• Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006122 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002719 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00053131 - Active, not recruiting
  recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003407 - Active, not recruiting
  untreated adult acute myeloid leukemia; Drug Toxicity; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006045 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00006250 - Active, not recruiting
  stage III grade 1 follicular lymphoma; stage III grade 2 follicular lymphoma; stage III grade 3 follicular lymphoma; ...
  
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003215 - Active, not recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
  
• Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002700 - Active, not recruiting
  untreated adult acute lymphoblastic leukemia; stage I adult lymphoblastic lymphoma; stage III adult lymphoblastic lymphoma; ...
  
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003436 - Active, not recruiting
  refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; childhood acute promyelocytic leukemia (M3); ...
  
• Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00107354 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00058084 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• Randomized Phase Iii-Study On Valproic Acid In Combination With All-Trans Retinoic Acid, Standard Induction- And Consolidation Therapy In Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00151255 - Recruiting
  Acute myeloid leukemia, age > 60 years
  
• Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00005613 - Active, not recruiting
  recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003405 - Active, not recruiting
  untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00109837 - Recruiting
  L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
  
• Pixantrone or Other Chemotherapy Drugs in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00101049 - Recruiting
  adult diffuse large cell lymphoma; adult diffuse mixed cell lymphoma; adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma; ...
  
• Combination Chemotherapy Plus Steroid Therapy in Treating Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003728 - Recruiting
  acute undifferentiated leukemia; childhood acute lymphoblastic leukemia; childhood lymphoblastic lymphoma
  
• Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00004071 - Completed
  stage IV prostate cancer; recurrent prostate cancer; Quality of Life
  
• Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00016016 - Completed
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Registry to Evaluate Novantrone (R) Effects in Worsening Multiple Sclerosis (RENEW)
  ClinicalTrials.gov Identifier: NCT00016614 - No longer recruiting
  Multiple Sclerosis
  
• Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy.
  ClinicalTrials.gov Identifier: NCT00183924 - Completed
  Prostate Adenocarcinoma
  
• Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00169208 - Completed
  Follicular Lymphoma
  
• Study Evaluating Mitoxantrone in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00146159 - Terminated
  Secondary Progressive Multiple Sclerosis
  
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002565 - Completed
  Lymphoma
  
• A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)
  ClinicalTrials.gov Identifier: NCT00304291 - Completed
  Neuromyelitis Optica; Myelitis, Transverse; Demyelinating Autoimmune Diseases, CNS; Autoimmune Diseases of the Nervous System
  
• A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00203086 - Completed
  Relapse Remitting Multiple Sclerosis
  
• Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002259 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Phase 2 Study of the Activity and Safety of Fludarabine, Cyclophosphamide, and Mitoxantrone Plus Rituximab (FCM-R) With Pegfilgrastim (Neulasta) as Frontline Therapy for Patients < 70 Years With Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00254410 - Suspended
  Chronic Lymphocytic Leukemia
  
• Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Refractory or Recurrent Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00002474 - Completed
  recurrent ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00047021 - Completed
  childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases
  
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003080 - Completed
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer
  
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00002805 - Completed
  recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia; Previously Treated Myelodysplastic Syndrome